Evaluation of perioperative pregabalin for prevention and attenuation of postoperative shoulder pain after thoracotomy in patients with lung cancer
Not Applicable
Completed
- Conditions
- ung cancer Neuropathic Pain Postoperative shoulder pain
- Registration Number
- JPRN-UMIN000014515
- Lead Sponsor
- Akita University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Shoulder pain severity was measured using a 100-mm visual analog scale (VAS) scoring system until post operative days 7.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pregabalin's effect on postoperative shoulder pain after thoracotomy in lung cancer patients?
How does perioperative pregabalin compare to standard analgesics in managing post-thoracotomy neuropathic shoulder pain in lung cancer patients?
Are there specific biomarkers that predict response to pregabalin in preventing postoperative shoulder pain following thoracotomy for lung cancer?
What are the potential adverse events associated with perioperative pregabalin use in lung cancer patients undergoing thoracotomy?
What combination therapies or alternative drugs show promise in managing post-thoracotomy shoulder pain in lung cancer patients compared to pregabalin?